{
    "medicine_id": "5984a26f8679e1d08af7772c6d05e25d91ed01bc",
    "platform_id": "DB04926",
    "metadata": {
        "name": "Cleviprex 0 5 mg 1mL Emulsion",
        "composition": "0 5 mg 1mL Neramexane",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in alzheimer s disease hearing loss and pain acute or chronic",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Neramexane is similar to memantine and acetylcholinesterase inhibitors in that neramexane targets the cognitive decline in Alzheimer s Disease by altering neurotransmitter signaling but not the underlying pathological mechanisms that cause the disease amyloid production or neurofibrillary tangle accumulation",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}